Correlation of soluble interleukin-2 receptor levels with severity of chronic hepatitis C virus liver injury and development of hepatocellular cancer

Surgery

Volumn 120, Issue 1, 1996, Pages 100-105

  Izzo, F ^a   Curley, S ^a   Maio, P ^a   Leonardi, E ^a   Imparato, L ^a   Giglio, S ^a   Cremona, F ^a   Castello, G ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2 RECEPTOR;

ADULT; AGED; ARTICLE; CANCER RISK; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE SEVERITY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPATHOGENESIS; LIVER BIOPSY; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECEPTOR DENSITY;

EID: 0029818485     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-6060(96)80247-9     Document Type: Article

References (30)

1. Esteban J Gonzalez A Hernandez J Evaluation of antibodies to hepatitis C virus in a study of transfusion-associated hepatitis N Engl J Med 323 1990 1107 1113
2. Curley SA Levin B Rich TA Liver and bile ducts Abeloff MD Armitage JO Lichter AS Niederhuber JE Clinical oncology 1995 Churchill Livingstone New York 1305 1372
3. Kiyosawa K Tanaka E Sodeyama T Transition of antibody to hepatitis C virus from chronic hepatitis to hepatocellular carcinoma Jpn J Cancer Res 81 1990 1089 1094
4. Verbaan H Widell A Lindgren S Lindmark B Nordenfelt E Eriksson S Hepatitis C in chronic liver disease: an epidemiological study based on 566 consecutive patients undergoing liver biopsy during a 10-year period J Int Med 232 1992 33 42
5. Kuo G Choo QL Alter HJ An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis Science 244 1989 362 364
6. Aach RD Stevens CE Hollinger FB Hepatitis C virus infection in post-transfusion hepatitis: an assay with first- and second-generation assays N Engl J Med 325 1991 1325 1329
7. Takano S Yokosuka O Imazeki F Tagawa M Omata M Incidence of hepatocellular carcinoma in chronic hepatitis B and C: a prospective study of 251 patients Hepatology 21 1995 650 655
8. Yamaguchi S Onji M Ohta Y Increased serum soluble interleukin 2 receptor levels in patients with viral liver disease Hepatogastroenterology 35 1988 245 248
9. Alberti A Chemello L Fattovich G Serum levels of soluble interleukin-2 receptors in acute and chronic viral hepatitis Dig Dis Sci 34 1989 1559 1563
10. Onji M Kondoh H Ohta Y Serial observation on lymphocyte subpopulations and interleukin 2 production of T cells from patients with acute viral hepatitis and chronic active hepatitis Hepatogastroenterology 35 1988 1 46
11. Bianchi L DeGroote J Desmet VJ Acute and chronic hepatitis revisited: classification of chronic hepatitis Lancet 2 1977 914 919
12. Diamantstein T Osawa H Mouzaki A Josimovic-Alasevic O Regulation of interleukin-2 receptor expression and receptor release Mol Immunol 23 1986 1165 1172
13. Muller C Knoflach P Zielinski CC Soluble interleukin 2 receptor in acute viral hepatitis and chronic liver disease Hepatology 10 1989 928 932
14. Chu CM Liaw YF Serum levels of soluble TAC peptide in acute and chronic hepatitis B virus infection Clin Immunol Immunopathol 53 1989 52 58
15. Hagiwara H Hayashi N Fusamoto H Kamada T Quantitative analysis of hepatitis C virus RNA: relationship between the replicative level and the various stages of the carrier states or the response to interferon therapy Gastroenterol Jpn 5 1993 48 51
16. Tanaka H Hiyama T Tsukuma H Cumulative risk of hepatocellular carcinoma in hepatitis C virus carriers: statistical estimations from cross-sectional data Jpn J Cancer Res 85 1994 485 490
17. Ikeda K Saitoh S Koida I A multivariate analysis of risk factors for hepatocellular carcinogenesis: a prospective observation of 795 patients with viral and alcoholic cirrhosis Hepatology 18 1993 47 53
18. Bridbord K Pathogenesis and prevention of hepatocellular carcinoma Cancer Detect Prev 14 1989 191 192
19. Rustgi V Epidemiology of hepatocellular cancer Ann Intern Med 108 1988 390 397
20. Nagasue N Kohno H Change Y-C Liver resection for hepatocellular carcinoma: results of 229 consecutive patients during 11 years Ann Surg 217 1993 375 384
21. Zhou XD Tang ZY Yu YQ Ma ZC Clinical evaluation of cryosurgery in the treatment of primary liver cancer: report of 60 cases Cancer 61 1988 1889 1893
22. Livraghi T Bolondi L Lazzaroni S Percutaneous ethanol injection in the treatment of hepatocellular carcinoma in cirrhosis Cancer 69 1992 925 929
23. Cottone M Turri M Caltagirone M Early detection of hepatocellular carcinoma associated with cirrhosis by ultrasound and alpha fetoprotein: a prospective study Hepatogastroenterology 35 1989 101 106
24. Maringhini A Cottone M Sciarrino E Ultrasonography and alpha-fetoprotein in diagnosis of hepatocellular carcinoma in cirrhosis Dig Dis Sci 33 1988 47 52
25. Colombo M de Franchis R del Nino E Hepatocellular carcinoma in Italian patients with cirrhosis N Engl J Med 325 1991 675 679
26. Curley SA Izzo F Gallipoli A deBellis M Cremona F Parisi V Identification and screening of 416 patients with chronic hepatitis at high risk to develop hepatocellular cancer Am Surg 222 1995 375 383
27. Liaw YF Tai DI Chen TJ Alpha-fetoprotein changes in the course of chronic hepatitis: relation to bridging hepatic fibrosis and hepatocellular carcinoma Liver 6 1986 133 139
28. Nomura F Ohnishi K Tanabe Y Clinical features and prognosis of hepatocellular carcinoma with reference to serum alpha-fetoprotein levels: analysis of 606 patients Cancer 64 1989 1700 1707
29. Suehiro T Sugimachi K Matsumata T Itasaka H Taketomi A Maeda T Protein induced by vitamin K absence or antagonist II as a prognostic marker in hepatocellular carcinoma Cancer 73 1994 2464 2471
30. Kasahara A Hayashi N Fusamoto H Clinical evaluation of plasma des-γ-carboxy prothrombin as a marker protein of hepatocellular carcinoma in patients with tumors of various sizes Dig Dis Sci 38 1993 2170 2176